Forte Bio-Pharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Forte Bio-Pharma

Access the complete profile.

Forte Bio-Pharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	44611 Pharmacies & Drug Stores
Address	8311 W Sunset Rd Suite 150 Las Vegas, NV 89113

Note: Revenues for privately held companies are statistical evaluations.


Forte Bio-Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Forte Bio-Pharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Forte Bio-Pharma is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Forte Bio-Pharma Annual Revenue and Growth Rate

Forte Bio-Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Forte Bio-Pharma's revenues are gauged from an analysis of company filings.

Forte Bio-Pharma's Income Statement (based on Industry Averages)

Forte Bio-Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Forte Bio-Pharma is developing and marketing. Forte Bio-Pharma doesn't have any recent trademark applications, indicating Forte Bio-Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ETHONIX pharmaceutical preparations for treatment of seizures and epilepsy; pharmaceutical products and substances for the treatment of central nervous system diseases; anti-convulsant	09/29/2023
ETHO CUPS Pharmaceutical preparations for treatment of seizures and epilepsy; pharmaceutical products and substances for the treatment of central nervous system diseases; anti-convulsant	09/29/2023

See all trademarks and details in the Full Report.

Market Share of Forte Bio-Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Forte Bio-Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Forte Bio-Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NECTARTEK	Las Vegas, NV	100
CNS SCRIPS	Las Vegas, NV	70
SECURA BIO	Las Vegas, NV	49
DRVITA INC. DBA EVA NUTRA	Las Vegas, NV	48
FORTE BIO-PHARMA	Las Vegas, NV	46
CANNVITAL NV	Las Vegas, NV	13

Future Competition: Forte Bio-Pharma's Fastest Growing Competitors

These companies are in the same general field as Forte Bio-Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)